Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:XRTX

Xyratex (XRTX) Stock Price, News & Analysis

Xyratex logo

About Xyratex Stock (NASDAQ:XRTX)

Key Stats

Today's Range
$1.23
$1.28
50-Day Range
N/A
52-Week Range
N/A
Volume
7,124 shs
Average Volume
19,806 shs
Market Capitalization
$2.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

Xyratex Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
32nd Percentile Overall Score

XRTX MarketRank™: 

Xyratex scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Xyratex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Xyratex has received no research coverage in the past 90 days.

  • Read more about Xyratex's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Xyratex has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.06% of the float of Xyratex has been sold short.
  • Short Interest Ratio / Days to Cover

    Xyratex has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xyratex has recently increased by 450.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Xyratex does not currently pay a dividend.

  • Dividend Growth

    Xyratex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.06% of the float of Xyratex has been sold short.
  • Short Interest Ratio / Days to Cover

    Xyratex has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xyratex has recently increased by 450.00%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Xyratex insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 6.90% of the stock of Xyratex is held by insiders.

    • Percentage Held by Institutions

      Only 0.23% of the stock of Xyratex is held by institutions.

    • Read more about Xyratex's insider trading history.
    Receive XRTX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Xyratex and its competitors with MarketBeat's FREE daily newsletter.

    XRTX Stock News Headlines

    Trump won. Buy this coin now.
    Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
    XORTX Initiates Precision Medicine Program
    XRTX:CA XORTX Therapeutics Inc.
    XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
    See More Headlines

    XRTX Stock Analysis - Frequently Asked Questions

    Xyratex shares reverse split before market open on Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Xyratex investors own include NVIDIA (NVDA), Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN) and EUDA Health (EUDA).

    Company Calendar

    Today
    11/21/2024
    Fiscal Year End
    12/31/2024

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:XRTX
    Fax
    N/A
    Employees
    N/A
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $14.00
    High Stock Price Target
    $14.00
    Low Stock Price Target
    $14.00
    Potential Upside/Downside
    +1,011.1%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    Net Income
    $-2,160,000.00
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Book Value
    $1.07 per share

    Miscellaneous

    Free Float
    1,861,000
    Market Cap
    $2.52 million
    Optionable
    Not Optionable
    Beta
    0.70
    The 10 Best AI Stocks to Own in 2024 Cover

    Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

    Get This Free Report

    This page (NASDAQ:XRTX) was last updated on 11/21/2024 by MarketBeat.com Staff
    From Our Partners